Established in 2013, we are a dynamic medical device company committed to developing advanced tissue reconstruction solutions. Our technology platforms enable us to create innovative surgical solutions that positively impact patients' lives.
Tissium's technology is based on research and intellectual property from the laboratories of Professor Robert Langer (MIT) and Professor Jeffrey M. Karp (Brigham and Women's Hospital), who co-founded the company with Christophe Bancel (CEO) and Maria Pereira (Chief Innovation Officer).
Currently, we have a pipeline of products in three verticals, including peripheral nerve repair, hernia repair, and cardiovascular sealing.
We strive to bring a new era of body repair by working relentlessly at TISSIUM, and we are continuously seeking talented individuals to join us on our mission. Learn more about our work and apply today!